| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.07B | 9.91B | 10.84B | 10.05B | 37.45B | 37.21B |
| Gross Profit | 2.74B | 2.70B | 2.77B | 2.91B | 25.12B | 26.13B |
| EBITDA | 24.83B | 10.28B | 18.30B | -3.81B | 15.51B | 10.84B |
| Net Income | 23.46B | 9.66B | 17.23B | -3.78B | 6.88B | 2.82B |
Balance Sheet | ||||||
| Total Assets | 53.87B | 53.65B | 53.13B | 46.84B | 41.77B | 82.09B |
| Cash, Cash Equivalents and Short-Term Investments | 9.59B | 2.94B | 9.97B | 15.95B | 14.04B | 32.78B |
| Total Debt | 2.73B | 2.59B | 2.59B | 1.42B | 474.82M | 3.80B |
| Total Liabilities | 6.62B | 5.47B | 5.52B | 9.58B | 6.75B | 55.05B |
| Stockholders Equity | 47.25B | 48.18B | 47.61B | 37.26B | 35.01B | 27.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.44B | -1.92B | 2.39B | -14.43B | 2.95B |
| Operating Cash Flow | 0.00 | 1.52B | -1.67B | 2.51B | -13.52B | 3.63B |
| Investing Cash Flow | 0.00 | 6.68B | 2.95B | -3.56B | -23.53B | 4.28B |
| Financing Cash Flow | 0.00 | -8.09B | -829.42M | -385.21M | 23.97B | -3.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥159.97B | 9.31 | 13.53% | 1.34% | -3.63% | -14.77% | |
62 Neutral | ¥78.70B | 9.86 | ― | 1.99% | -0.29% | 119.59% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥195.25B | 20.35 | 25.11% | 1.15% | -8.58% | -42.94% | |
59 Neutral | ¥8.87T | 50.33 | 4.25% | 1.99% | -4.84% | -48.25% | |
57 Neutral | ¥61.75B | 12.75 | ― | 2.73% | -1.96% | 26.37% | |
48 Neutral | ¥395.53B | 8.31 | ― | ― | -12.38% | 31.41% |